CA2730221C — Oil in water emulsion comprising nsaids and quaternary ammonium halides
Assigned to Santen SAS · Expires 2016-02-02 · 10y expired
What this patent protects
Oil-in-water emulsion comprising a non-steroidal anti-inflammatory drug and a quaternary ammonium halide in which the nitrogen atom is substituted by one or more alkyl group having at least 16 carbon atoms useful for the prevention and treatment of inflammation in the eye, and pr…
USPTO Abstract
Oil-in-water emulsion comprising a non-steroidal anti-inflammatory drug and a quaternary ammonium halide in which the nitrogen atom is substituted by one or more alkyl group having at least 16 carbon atoms useful for the prevention and treatment of inflammation in the eye, and process for manufacturing thereof.
Drugs covered by this patent
- Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.